According to the Multiple Myeloma Research Foundation (MMRF) consolidated audit of December 31, 2023 (Note 2, Summary of Significant Accounting Policies, Contributed Services), MMRF received donated services in 2023 on which it placed a total value of approximately $794,000; the donated services "consisted of legal, consulting, printing and promotional services." [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |
According to the Multiple Myeloma Research Foundation (MMRF) consolidated audit of December 31, 2023 (Note 2, Summary of Significant Accounting Policies, Royalties): "...The MMRF previously provided a $1,000,000 award to a biotech company. As part of the award, the MMRF receives royalty payments based on net revenues. Cumulative payments totaled $4,525,000 as of December 31, 2023. There was no royalty income in 2023 or 2022 related to its royalty agreement." |
According to the Multiple Myeloma Research Foundation (MMRF) 2023 tax filing, MMRF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III): Regarding severance payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 4a): "Charles Volpe, Director, PR & Communications, received a severance payment of $31,500..." [Charles Volpe had reported total compensation of $228,149 in 2023 (IRS Form 990, Schedule J, Part II)]. Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7): "Individuals included in Schedule J, Part II received a discretionary bonus during calendar year 2023, which was included...as taxable Medicare wages." MMRF reports "Bonus & incentive compensation" payments to 16 individuals in 2023, including $150,000 paid to Michael Andreini, President & CEO. The reported total compensation in 2023 for Michael Andreini is $552,533. The remaining fifteen individuals received "Bonus & incentive compensation" that ranged from $8,000 to $122,000, with associated reported total compensation in 2023 ranging from $186,081 to $413,942 (IRS Form 990, Schedule J, Part II). |
According to the Multiple Myeloma Research Foundation (MMRF) tax filing for the fiscal year ended December 31, 2023, MMRF reports re: Supplemental Information to Form 990 or 990-EZ (IRS Form 990, Schedule O): Regarding family or business relationships among officers, directors, trustees, or key employees (IRS Form 990, Part VI, Section A, Line 2): "Kathy Giusti, Founder & former Chief Mission Officer, and Karen Andrews, board member[,] have a family relationship." |
